DE3910578A1 - Mittel zur transdermalen applikation enthaltend gestoden - Google Patents
Mittel zur transdermalen applikation enthaltend gestodenInfo
- Publication number
- DE3910578A1 DE3910578A1 DE19893910578 DE3910578A DE3910578A1 DE 3910578 A1 DE3910578 A1 DE 3910578A1 DE 19893910578 DE19893910578 DE 19893910578 DE 3910578 A DE3910578 A DE 3910578A DE 3910578 A1 DE3910578 A1 DE 3910578A1
- Authority
- DE
- Germany
- Prior art keywords
- estrogen
- penetration
- layer
- enhancing agents
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (35)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19893910578 DE3910578A1 (de) | 1989-03-29 | 1989-03-29 | Mittel zur transdermalen applikation enthaltend gestoden |
EP89912449A EP0394429B1 (de) | 1988-10-27 | 1989-10-11 | Mittel zur transdermalen applikation enthaltend gestoden |
EP89118855A EP0370220B1 (de) | 1988-10-27 | 1989-10-11 | Mittel zur transdermalen Applikation enthaltend Gestoden |
ES89118855T ES2081823T3 (es) | 1988-10-27 | 1989-10-11 | Agente para la aplicacion transdermica, que contiene gestoden. |
DE58909570T DE58909570D1 (de) | 1988-10-27 | 1989-10-11 | Mittel zur transdermalen applikation enthaltend gestoden |
JP51155389A JP3238389B2 (ja) | 1988-10-27 | 1989-10-11 | ゲストデン含有の経皮適用のための薬剤 |
AT89912449T ATE132751T1 (de) | 1988-10-27 | 1989-10-11 | Mittel zur transdermalen applikation enthaltend gestoden |
HU896546A HU210549B (en) | 1988-10-27 | 1989-10-11 | Process for producing transdermally applicable pharmaceutical composition containing gestodene |
PCT/EP1989/001200 WO1990004397A1 (de) | 1988-10-27 | 1989-10-11 | Mittel zur transdermalen applikation enthaltend gestoden |
EP93250189A EP0573133A1 (de) | 1988-10-27 | 1989-10-11 | Mittel zur transdermalen Applikation das Gestoden enthält |
MX017971A MX173621B (es) | 1988-10-27 | 1989-10-16 | Agente para administracion transdermica que contiene gestodeno |
IL9200789A IL92007A (en) | 1988-10-27 | 1989-10-16 | Healing and contraceptive preparations that are inserted through the skin and contain Gestudin |
IE337689A IE81077B1 (en) | 1988-10-27 | 1989-10-20 | Gestodene-containing agent for transdermal administration |
IE970562A IE970562A1 (sk) | 1988-10-27 | 1989-10-20 | |
CN89108149A CN1036836C (zh) | 1988-10-27 | 1989-10-25 | 制备含有孕二烯酮的透皮治疗***的方法 |
AU43747/89A AU4374789A (en) | 1988-10-27 | 1989-10-25 | Gestodene-containing agent for transdermal administration |
KR1019890015580A KR0137463B1 (ko) | 1988-10-27 | 1989-10-26 | 게스토덴을 함유하는 경피 투여용 제제 |
CA002001618A CA2001618C (en) | 1988-10-27 | 1989-10-26 | Gestodene-containing agent for transdermal administration |
PL28752689A PL162410B1 (pl) | 1989-03-29 | 1989-10-26 | Sposób wytwarzania poprzezskórnego ukladu terapeutycznegoNumer zgloszenia, z którego nastapilo wydzielenie:282033 PL |
PL28203389A PL162400B1 (pl) | 1989-03-29 | 1989-10-26 | Sposób wytwarzania poprzezskórnego ukladu terapeutycznego PL |
CS896089A CZ277870B6 (en) | 1989-03-29 | 1989-10-27 | Preparation containing gestoden for transdermal application |
PT92131A PT92131B (pt) | 1988-10-27 | 1989-10-27 | Processo para a preparacao de meios para aplicacao transdermica contendo gestodeno |
SK608989A SK608989A3 (en) | 1989-03-29 | 1989-10-27 | The composition for transdermal application with gestodene content |
DK199001385A DK175804B1 (da) | 1988-10-27 | 1990-06-06 | Middel til transdermal applikation indeholdende gestoden |
BG092281A BG92281A (bg) | 1988-10-27 | 1990-06-21 | Метод за получаване на трансдермални системи |
NO902840A NO180567C (no) | 1988-10-27 | 1990-06-26 | Befruktningshindrende og/eller syklusregulerende middel for transdermal applikasjon |
FI903213A FI100456B (fi) | 1988-10-27 | 1990-06-26 | Gestodeenia sisältävän vaikuttavan aineen transdermaaliseen antoon tar koitetun välineen käyttö raskauden ehkäisyyn |
SU904830921A RU2044541C1 (ru) | 1989-03-29 | 1990-06-26 | Способ получения лечебного средства для трансдермального применения |
AU30011/92A AU3001192A (en) | 1988-10-27 | 1992-12-09 | Gestodene-containing agent for transdermal administration |
US08/403,137 US5788984A (en) | 1988-10-27 | 1995-03-13 | Gestodene-containing agent for transdermal administration |
NO951592A NO951592D0 (no) | 1988-10-27 | 1995-04-26 | Fremgangsmåte for fremstilling av et transdermalt terapeutisk system |
AU20596/95A AU2059695A (en) | 1988-10-27 | 1995-06-08 | Gestodene-containing agent for transdermal administration |
GR960400488T GR3019079T3 (en) | 1988-10-27 | 1996-02-22 | Gestode composition for transdermal application |
CN96109379A CN1069829C (zh) | 1988-10-27 | 1996-07-30 | 含有孕二烯酮的透皮应用的药剂 |
AU77416/98A AU714979B2 (en) | 1988-10-27 | 1998-07-21 | Gestodene-containing agent for transdermal administration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19893910578 DE3910578A1 (de) | 1989-03-29 | 1989-03-29 | Mittel zur transdermalen applikation enthaltend gestoden |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3910578A1 true DE3910578A1 (de) | 1990-10-04 |
Family
ID=6377622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19893910578 Withdrawn DE3910578A1 (de) | 1988-10-27 | 1989-03-29 | Mittel zur transdermalen applikation enthaltend gestoden |
Country Status (5)
Country | Link |
---|---|
CZ (1) | CZ277870B6 (sk) |
DE (1) | DE3910578A1 (sk) |
PL (2) | PL162410B1 (sk) |
RU (1) | RU2044541C1 (sk) |
SK (1) | SK608989A3 (sk) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993018774A1 (de) * | 1992-03-21 | 1993-09-30 | Entec Gesellschaft Für Endokrinologische Technologie M.B.H. | Verwendung von östriol zur behandlung von klimakterischer osteoporose |
DE19526864A1 (de) * | 1995-07-22 | 1997-01-23 | Labtec Gmbh | Hormonpflaster |
DE10019171A1 (de) * | 2000-04-07 | 2001-10-18 | Schering Ag | Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1191927E (pt) | 1999-07-02 | 2003-07-31 | Lohmann Therapie Syst Lts | Sistema de microrreservatorios a base de polissiloxanos e solventes ambifilicos |
WO2008136699A1 (fr) * | 2007-05-04 | 2008-11-13 | Igor Alexandrovich Bazikov | Patch transdermique à microcapsules et procédé de fabrication correspondant |
-
1989
- 1989-03-29 DE DE19893910578 patent/DE3910578A1/de not_active Withdrawn
- 1989-10-26 PL PL28752689A patent/PL162410B1/pl unknown
- 1989-10-26 PL PL28203389A patent/PL162400B1/pl unknown
- 1989-10-27 CZ CS896089A patent/CZ277870B6/cs not_active IP Right Cessation
- 1989-10-27 SK SK608989A patent/SK608989A3/sk unknown
-
1990
- 1990-06-26 RU SU904830921A patent/RU2044541C1/ru active
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993018774A1 (de) * | 1992-03-21 | 1993-09-30 | Entec Gesellschaft Für Endokrinologische Technologie M.B.H. | Verwendung von östriol zur behandlung von klimakterischer osteoporose |
AU665997B2 (en) * | 1992-03-21 | 1996-01-25 | Entec Gesellschaft Fur Endokrinologische Technologie M.B.H. | Use of estriol for treating climacteric osteoporosis |
US5614213A (en) * | 1992-03-21 | 1997-03-25 | Entec Gesellschaft Fuer Endokrinologische Technologie M.B.H. | Use of estriol for treatment of climacteric osteoporosis |
DE19526864A1 (de) * | 1995-07-22 | 1997-01-23 | Labtec Gmbh | Hormonpflaster |
US5985311A (en) * | 1995-07-22 | 1999-11-16 | Labtec Gesellschaft Fuer Techologische Forschung Und Entwicklung Mbh | Transdermal hormone patch |
DE10019171A1 (de) * | 2000-04-07 | 2001-10-18 | Schering Ag | Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe |
Also Published As
Publication number | Publication date |
---|---|
PL162400B1 (pl) | 1993-11-30 |
SK278438B6 (en) | 1997-05-07 |
PL287526A1 (en) | 1991-10-21 |
PL282033A1 (en) | 1991-03-11 |
CZ277870B6 (en) | 1993-06-16 |
SK608989A3 (en) | 1997-05-07 |
PL162410B1 (pl) | 1993-11-30 |
CZ608989A3 (en) | 1993-02-17 |
RU2044541C1 (ru) | 1995-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0394429B1 (de) | Mittel zur transdermalen applikation enthaltend gestoden | |
EP0655916B1 (de) | Mittel zur transdermalen applikation enthaltend 3-keto-desogestrel | |
EP0744944B1 (de) | Transdermale therapeutische systeme enthaltend sexualsteroide | |
DE69430917T2 (de) | 3-l-MENTHOXY-PROPANE-1, 2-DIOL ALS LÖSUNGSVERMITTLER UND EXTERNE ZUBEREITUNG, DIE DIESEN ENTHÄLT | |
DE4329242A1 (de) | Mittel zur transdermalen Applikation enthaltend Gestodenester | |
EP1027889B1 (de) | Mittel zur transdermalen Applikation enthaltend Ergolin-Derivate | |
DD286293A5 (de) | Mittel zur transdermalen applikation enthaltend gestoden | |
DE3910578A1 (de) | Mittel zur transdermalen applikation enthaltend gestoden | |
EP0744943A1 (de) | Mittel zur transdermalen applikation enthaltend desogestrel | |
DE3943385A1 (de) | Mittel zur transdermalen applikation enthaltend rolipram | |
EP0848620A1 (de) | Mittel zur transdermalen applikation enthaltend ester des 3-ketodegestrel | |
DE4240806A1 (de) | Mittel zur transdermalen Applikation enthaltend 14alpha,17alpha-Ethanoestra-1,3,5(10)-trien-3,17beta-diol | |
WO1995020392A1 (de) | MITTEL ZUR TRANSDERMALEN APPLIKATION ENTHALTEND 14α,17α-ETHANOESTRA-1,3,5(10)-TRIEN-3,17β-DIOL | |
DE19613698A1 (de) | Mittel zur transdermalen Applikation enthaltend Ester des 13-Ethyl-17ß-hydroxy-11-methylen-18,19-dinor-17alpha-pregn-4-en-20-yn-3-ons |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8127 | New person/name/address of the applicant |
Owner name: SCHERING AG, 13353 BERLIN, DE |
|
8141 | Disposal/no request for examination |